Xenon

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Xenon
DrugBank Accession Number
DB13453
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 131.293
Monoisotopic: 131.904154457
Chemical Formula
Xe
Synonyms
  • Xenon
  • Xenon gas

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcebutololXenon may decrease the antihypertensive activities of Acebutolol.
AceclofenacThe risk or severity of hypertension can be increased when Aceclofenac is combined with Xenon.
AcemetacinThe risk or severity of hypertension can be increased when Xenon is combined with Acemetacin.
Acetylsalicylic acidThe risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Xenon.
AlbuterolThe risk or severity of hypertension can be increased when Salbutamol is combined with Xenon.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now

Categories

ATC Codes
N01AX15 — Xenon
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of inorganic compounds known as homogeneous noble gases. These are inorganic non-metallic compounds in which the largest atom is a halogen atom.
Kingdom
Inorganic compounds
Super Class
Homogeneous non-metal compounds
Class
Homogeneous noble gases
Sub Class
Not Available
Direct Parent
Homogeneous noble gases
Alternative Parents
Not Available
Substituents
Homogeneous noble gas
Molecular Framework
Not Available
External Descriptors
monoatomic xenon (CHEBI:49956)
Affected organisms
Not Available

Chemical Identifiers

UNII
3H3U766W84
CAS number
7440-63-3
InChI Key
FHNFHKCVQCLJFQ-UHFFFAOYSA-N
InChI
InChI=1S/Xe
IUPAC Name
xenon
SMILES
[Xe]

References

General References
Not Available
KEGG Compound
C13373
ChemSpider
22427
RxNav
11363
ChEBI
49957
ChEMBL
CHEMBL1236802
PDBe Ligand
XE
Wikipedia
Xenon
PDB Entries
1c10 / 1c1m / 1c3l / 1c62 / 1c65 / 1c68 / 1c6b / 1c6e / 1c6h / 1c6k
show 127 more

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
Not AvailableActive Not RecruitingNot AvailableCystic Fibrosis (CF)1somestatusstop reasonjust information to hide
Not AvailableActive Not RecruitingTreatmentEosinophilic Asthma1somestatusstop reasonjust information to hide
Not AvailableCompletedNot AvailableAnesthesia therapy1somestatusstop reasonjust information to hide
Not AvailableCompletedNot AvailableCystic Fibrosis (CF)1somestatusstop reasonjust information to hide
Not AvailableCompletedNot AvailableEncephalopathies / Perinatal Asphyxia1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Gas
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP0Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity0 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at June 23, 2017 20:42 / Updated at July 18, 2023 22:57